
Health
AI drug developer Alto Neuroscience raises $25M and more digital health fundings
Alto Neuroscience, which uses AI to identify biomarkers to develop targeted psychiatric medicine options, announced it closed a $25 million equity investment with new investor Alpha Wave Ventures and entered into a credit facility for […]